Literature DB >> 21673349

Erg is required for self-renewal of hematopoietic stem cells during stress hematopoiesis in mice.

Ashley P Ng1, Stephen J Loughran, Donald Metcalf, Craig D Hyland, Carolyn A de Graaf, Yifang Hu, Gordon K Smyth, Douglas J Hilton, Benjamin T Kile, Warren S Alexander.   

Abstract

Hematopoietic stem cells (HSCs) are rare residents of the bone marrow responsible for the lifelong production of blood cells. Regulation of the balance between HSC self-renewal and differentiation is central to hematopoiesis, allowing precisely regulated generation of mature blood cells at steady state and expanded production at times of rapid need, as well as maintaining ongoing stem cell capacity. Erg, a member of the Ets family of transcription factors, is deregulated in cancers; and although Erg is known to be required for regulation of adult HSCs, its precise role has not been defined. We show here that, although heterozygosity for functional Erg is sufficient for adequate steady-state HSC maintenance, Erg(+/Mld2) mutant mice exhibit impaired HSC self-renewal after bone marrow transplantation or during recovery from myelotoxic stress. Moreover, although mice functionally compromised for either Erg or Mpl, the receptor for thrombopoietin, a key regulator of HSC quiescence, maintained sufficient HSC activity to sustain hematopoiesis, Mpl(-/-) Erg(+/Mld2) compound mutant mice displayed exacerbated stem cell deficiencies and bone marrow failure. Thus, Erg is a critical regulator of adult HSCs, essential for maintaining self-renewal at times of high HSC cycling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21673349     DOI: 10.1182/blood-2011-03-344739

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

Review 1.  Biomaterial strategies for stem cell maintenance during in vitro expansion.

Authors:  Xiang-Zhen Yan; Jeroen J J P van den Beucken; Sanne K Both; Pi-Shan Yang; John A Jansen; Fang Yang
Journal:  Tissue Eng Part B Rev       Date:  2013-12-05       Impact factor: 6.389

2.  MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation.

Authors:  Y Huang; J A I Thoms; M L Tursky; K Knezevic; D Beck; V Chandrakanthan; S Suryani; J Olivier; A Boulton; E N Glaros; S R Thomas; R B Lock; K L MacKenzie; J H Bushweller; J W H Wong; J E Pimanda
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

3.  Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.

Authors:  K Nowek; S M Sun; L Bullinger; E M J Bindels; C Exalto; M K Dijkstra; K van Lom; H Döhner; S J Erkeland; B Löwenberg; M Jongen-Lavrencic
Journal:  Leukemia       Date:  2015-07-15       Impact factor: 11.528

Review 4.  Transcription factor-mediated reprogramming toward hematopoietic stem cells.

Authors:  Wataru Ebina; Derrick J Rossi
Journal:  EMBO J       Date:  2015-02-20       Impact factor: 11.598

5.  Emergence of ETS transcription factors as diagnostic tools and therapeutic targets in prostate cancer.

Authors:  Said Rahim; Aykut Uren
Journal:  Am J Transl Res       Date:  2013-04-19       Impact factor: 4.060

6.  Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia.

Authors:  Catherine L Carmichael; Donald Metcalf; Katya J Henley; Elizabeth A Kruse; Ladina Di Rago; Sandra Mifsud; Warren S Alexander; Benjamin T Kile
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-30       Impact factor: 11.205

Review 7.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

8.  Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia.

Authors:  Jian Zhong Tang; Catherine L Carmichael; Wei Shi; Donald Metcalf; Ashley P Ng; Craig D Hyland; Nancy A Jenkins; Neal G Copeland; Viive M Howell; Zhizhuang Joe Zhao; Gordon K Smyth; Benjamin T Kile; Warren S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

Review 9.  Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.

Authors:  Qu Deng; Dean G Tang
Journal:  Endocr Relat Cancer       Date:  2015-08-18       Impact factor: 5.678

10.  Structural and dynamic studies of the transcription factor ERG reveal DNA binding is allosterically autoinhibited.

Authors:  Michael C Regan; Peter S Horanyi; Edward E Pryor; Jessica L Sarver; David S Cafiso; John H Bushweller
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.